Friedl-Naderer Johanna 4
4 · Vir Biotechnology, Inc. · Filed Feb 24, 2023
Insider Transaction Report
Form 4
Friedl-Naderer Johanna
Chief Business Officer, Global
Transactions
- Award
Stock Option (Right to Buy)
2023-02-22+70,000→ 70,000 totalExercise: $27.01Exp: 2033-02-21→ Common Stock (70,000 underlying) - Award
Common Stock
2023-02-22+60,000→ 150,000 total
Footnotes (2)
- [F1]Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan.
- [F2]25% of the shares subject to the stock option vest and become exercisable on February 22, 2024, and the remainder vest in 36 equal monthly installments thereafter.